Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Williams Companies Inc (WMB) Price & Performance

Amylx Pharmaceuticals IncTrade
Williams Companies IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Williams Companies Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Williams Companies Inc trades at $71.97 (market cap $88.45B). The key difference: Williams Companies Inc is far larger — about 33.5× Amylx Pharmaceuticals Inc's market cap, and Williams Companies Inc pays a 2.9% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXWMB
Market Cap
$2.64B$88.45B
Sector
HealthEnergy
52-Week High
$24.19$79.40
52-Week Low
$7.82$56.51
Enterprise Value
$2.39B$119.07B
Dividend Yield
2.9%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Williams Companies Inc

Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.

Read more on WMB